Stacy Sanders
Acute Care · Columbia, SCNPI 1679187603
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (50.6%), food and beverage and education — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Edwards Lifesciences at 52.3% of the total.
Across 68 payments — averaging $80.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$3K
- Boston Scientific$2K
- E.r. Squibb & Sons, L.L.C.$148
- Avanos Medical$138
- Amgen$74
- Esperion Therapeutics, Inc.$63
- plus $458 from 14 others
What the payments were for
- Travel & lodging$2,78651%
- Food & beverage$2,71649%
- Education$10%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 22 | $2,876 |
| Boston Scientific | 11 | $1,745 |
| E.r. Squibb & Sons, L.L.C. | 3 | $148 |
| Avanos Medical | 1 | $138 |
| Amgen | 4 | $74 |
| Esperion Therapeutics, Inc. | 4 | $63 |
| Philips North America LLC | 2 | $62 |
| Scpharmaceuticals Inc. | 3 | $52 |
| Kiniksa Pharmaceuticals, Ltd. | 3 | $52 |
| Lexicon Pharmaceuticals, Inc. | 2 | $47 |
| Atricure, Inc. | 2 | $47 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $35 |
| AstraZeneca | 2 | $31 |
| Amryt Pharma Holdings Ltd | 1 | $24 |
| Medtronic | 1 | $23 |
| Pfizer | 1 | $21 |
| Novo Nordisk | 1 | $18 |
| Actelion Pharmaceuticals US, Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $15 |
| Boehringer Ingelheim | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,503 in reported general payments places this provider in the 85th percentile of 339 acute care providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Valsartan | 14 | $559 |
| ClopidogrelClopidogrel Bisulfate | 33 | $464 |
| Pantoprazole Sodium | 12 | $252 |
Paid to pharmacies, not to this prescriber.
Other acute care in Columbia
- Michael GajewskiColumbia$62K
- Micheal BungerColumbia$15K
- Robin TrauflerColumbia$12K
- Linda VanduysColumbia$7K
- Aziz PetiwalaColumbia$7K
- Christina AdkinsColumbia$6K
- Brandon PalmerColumbia$6K
- Sarah Ford-SightlerColumbia$6K
- Jessica WheelerColumbia$6K
- Jazmine PorterfieldColumbia$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.